News

DiaMedica Announces Regulatory Clearance to Initiate Bridging Clinical Trial for DM199
DiaMedica Completes Second Tranche of Non-Brokered Private Placement With Hermed Capital
DiaMedica Completes First Tranche of Non-Brokered Private Placement with Hermed Capital
DiaMedica Announces Strategic Investment by Hermed Capital Healthcare Fund
DiaMedica Announces U.S. Composition of Matter Patent for DM199
DiaMedica Appoints Dr. Todd Verdoorn as Chief Scientific Officer
DiaMedica to Present at the 2016 BFC Global Healthcare Business Development and Investment Conference
DiaMedica Engages JV Public Relations New York
DiaMedica Completes Non-Brokered Private Placement
DiaMedica Appoints Dr. Todd Verdoorn as Vice President of Neuroscience